ACUVAIL® ophthalmic solution is indicated for the treatment of pain and inflammation following cataract surgery.

Recommended Dosing

Patient Dosing

One drop of ACUVAIL® should be applied to the affected eye twice daily beginning 1 day prior to cataract surgery, continued on the day of surgery, and through the first 2 weeks of the postoperative period.

Use With Other Topical Ophthalmic Medications

ACUVAIL® ophthalmic solution may be administered in conjunction with other topical ophthalmic medications such as alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics. Drops should be administered at least 5 minutes apart.

Dosage Forms And Strengths

• 30 single-use vials filled with 0.4 mL of ketorolac tromethamine ophthalmic solution, 0.45% (4.5 mg/mL)
• 60 single-use vials filled with 0.4 mL of ketorolac tromethamine ophthalmic solution, 0.45% (4.5 mg/mL)

Storage And Handling

ACUVAIL® (ketorolac tromethamine) Ophthalmic Solution 0.45% is available as a sterile solution supplied in clear, LDPE, single-use vials packaged in 6 foil pouches, 5 vials per pouch:

30 Single-Use Vials 0.4 mL each: NDC 0023-3507-30
60 Single-Use Vials 0.4 mL each: NDA 0023-3507-60

Storage

Store at 15°-30° C (59°-86° F). Store the vials in the pouch, protected from light. Fold pouch ends closed.

Revised: 10/2012. Allergan Inc.

Last reviewed on RxList: 11/30/2012
This monograph has been modified to include the generic and brand name in many instances.